S. Kumar et al. / Polyhedron 72 (2014) 140–146
141
{(2,5-CH3)2C6H3O}2PS2Na, {(3,4-CH3)2C6H3O}2PS2Na, {(3,5-CH3)2
C6H3O}2PS2Na and (4-Cl-3-CH3C6H3O)2PS2Na, were synthesized
according to a literature procedure for tolyldithiophosphates [21].
Moisture was carefully excluded for the synthesis of the ligands
throughout the experimental manipulations using standard
Schlenk techniques. Nickel was estimated gravimetrically as
nickel(II)dimethylglyoximate. Chlorine was estimated by Volhard’s
method [22]. Elemental analyses (C, H, N and S) were conducted
using an Elemental Analyser Vario EL-III (Indian Institute of Integra-
tive Medicine, Jammu). Infrared spectra were recorded in the range
4000–200 cmꢀ1 on a Perkin Elmer-spectrum RX1 FT-IR spectropho-
tometer (SAIF, Panjab University, Chandigarh). The 1H and 13C NMR
spectra were recorded in CDCl3 using TMS as an internal reference.
The 31P NMR spectra were recorded in CDCl3 using H3PO4 (85%) as
an external reference on a Bruker Avance III 400 MHz (Department
of Chemistry, University of Jammu, Jammu). All chemical shifts are
reported in d units downfield from TMS = d 0 ppm. The cyclic vol-
tammogram was recorded on an Autolabs (Department of Chemis-
try, University of Jammu, Jammu). The potential was applied
between the reference electrode (Ag/AgCl) and the working elec-
trode (gold electrode) and the current was measured between the
working electrode and the counter electrode (platinum wire).
0.1 M phosphate buffer solution (pH 7.0) was used. For antifungal
studies, the fungus Penicillium chrysogenum was procured from
the Department of Botany, University of Jammu, Jammu. All the
glasswares and materials used for the antifungal activity measure-
ments were sterilized in an autoclave.
{(3,4-CH3)2C6H3O}2PS2Na (1.00 g, 2.77 mmol). The resulting solid
was recrystallized from a chloroform/n-hexane mixture (3:1) at
room temperature. Yield: 0.90 g (90%); M.p. 169–171 °C (dec);
Anal. Calc. for C32H36O4P2S4Ni: C, 52.40; H, 4.95; S, 17.49; Ni,
8.00; Found: C, 52.33; H, 4.89; S, 17.46; Ni, 7.86%; IR (KBr,
cmꢀ1): 1088 s [
573 m [
PꢀS]sym, 368 w [
m
(P)ꢀOꢀC], 861 s [
m
PꢀOꢀ(C)], 653 s [
m
PꢀS]asym
,
m
m
NiꢀS]; 1H NMR (CDCl3, ppm): 2.29
(s, 12H, 4–CH3), 2.31 (s, 12H, 3–CH3), 7.16 (d, J = 7.6 Hz, 4H, H6),
7.28 (s, 4H, H2), 7.40 (d, J = 8 Hz, 4H, H5); 13C NMR (CDCl3, ppm):
19.2 (4–CH3), 19.9 (3–CH3), 118.3 (C6), 122.2 (C2), 130.4 (C4–
CH3), 134.4 (C5), 138.2 (C3–CH3), 147.8 (C1–O); 31P NMR (CDCl3,
ppm): 86.0 (s).
2.2.4. Synthesis of [{3,5-(CH3)2C6H3O}2PS2]2Ni (4)
Complex 4 was prepared by a similar procedure as described for
complex 1, using Ni(NO3)2ꢁ6H2O (0.40 g, 1.37 mmol) and {(3,5-
CH3)2C6H3O}2PS2Na (1.00 g, 2.77 mmol). The resulting solid was
recrystallized from a chloroform/n-hexane mixture (3:1) at room
temperature. Yield: 0.92 g (92%); M.p. 187–189 °C (dec); Anal. Calc.
for C32H36O4P2S4Ni: C, 52.40; H, 4.95; S, 17.49; Ni, 8.00; Found: C,
52.32; H, 4.81; S, 17.43; Ni, 7.92%; IR (KBr, cmꢀ1): 1101 s
[
m
(P)ꢀOꢀC], 858 s [
m
PꢀOꢀ(C)], 654 s [
m
PꢀS]asym, 557 m [
m
PꢀS]sym
,
371 w [
m
NiꢀS]; 1H NMR (CDCl3, ppm): 2.35 (s, 24H, 3,5–(CH3)2),
6.80 (s, 8H, H2,6), 7.08 (s, 4H, H4); 13C NMR (CDCl3, ppm): 21.3
(3,5–(CH3)2), 118.9 (C2,6), 127.7 (C4), 139.5 (C3,5–CH3), 149.6 (C1–
O); 31P NMR (CDCl3, ppm): 84.9 (s).
2.2.5. Synthesis of [(4-Cl-3-CH3C6H3O)2PS2]2Ni (5)
2.2. Synthesis of complexes 1–5
Complex 5 was prepared by a similar procedure as described for
complex 1, using Ni(NO3)2ꢁ6H2O (0.36 g, 1.24 mmol) and (4-Cl-3-
CH3C6H3O)2PS2Na (1.00 g, 2.49 mmol). The resulting solid was
recrystallized from a chloroform/n-hexane mixture (3:1) at room
temperature. Yield: 0.90 g (90%); M.p. 144–146 °C (dec); Anal. Calc.
for C28H24O4P2S4Cl4Ni: C, 41.25; H, 2.97; S, 15.73; Cl, 17.40; Ni,
7.20; Found: C, 41.16; H, 2.75; S, 15.54; Cl, 17.36; Ni, 7.09%; IR
2.2.1. Synthesis of [{2,4-(CH3)2C6H3O}2PS2]2Ni (1)
To
a
stirred aqueous solution of Ni(NO3)2ꢁ6H2O (0.40 g,
1.37 mmol), an aqueous solution of {(2,4-CH3)2C6H3O}2PS2Na
(1.00 g, 2.77 mmol) was added in a 1:2 M ratio with constant stir-
ring. A solid precipitated immediately. After 30 min of stirring, the
reaction contents were filtered to obtain the complex [{(2,4-CH3)2
C6H3O}2PS2]2Ni (1) as a purple powdery solid. The complex was
recrystallized from chloroform/n-hexane mixture (3:1) at room
temperature. Yield: 0.91 g (91%); M.p. 172–174 °C (dec); Anal. Calc.
for C32H36O4P2S4Ni: C, 52.40; H, 4.95; S, 17.49; Ni, 8.00; Found: C,
52.35; H, 4.71; S, 17.47; Ni, 7.91%; IR (KBr, cmꢀ1): 1105 s
(KBr, cmꢀ1): 1157
PꢀS]asym, 635 m [
s
[
m
(P)ꢀOꢀC], 971
s
[
m
PꢀOꢀ(C)], 704
s
[m
m
PꢀS]sym, 381 w [
m
NiꢀS]; 1H NMR (CDCl3,
ppm): 2.27 (s, 24H, 3–CH3), 7.13 (d, J = 8 Hz, 4H, H6), 7.18 (s, 4H,
H2), 7.31 (d, J = 8.8 Hz, 4H, H3); 13C NMR (CDCl3, ppm): 19.7 (3–
CH3), 120.6 (C6), 123.9 (C2), 127.1 (C4–Cl), 128.7 (C5–CH3), 135.4
(C3), 151.3 (C1–O); 31P NMR (CDCl3, ppm): 86.1 (s).
[
m
(P)ꢀOꢀC], 869 s [
m
PꢀOꢀ(C)], 650 s [
m
PꢀS]asym, 572 m [
m
PꢀS]sym
,
370 w [
m
NiꢀS]; 1H NMR (CDCl3, ppm): 2.30 (s, 12H, 2–CH3), 2.36 (s,
All the complexes 1–5 were obtained as purple solids.
12H, 4–CH3), 6.87 (d, J = 8 Hz, 4H, H6), 7.07 (d, J = 8 Hz, 4H, H5), 7.37
(s, 4H, H3); 13C NMR (CDCl3, ppm): 17.3 (2–CH3), 20.8 (4–CH3),
120.8 (C6), 127.4 (C2–CH3), 129.9 (C5), 132.1 (C4–CH3), 135.4 (C3),
146.8 (C1–O); 31P NMR (CDCl3, ppm): 85.8 (s).
R4
R5
C5 C6
C4 C1
C3 C2
R3
O
2.2.2. Synthesis of [{2,5-(CH3)2C6H3O}2PS2]2Ni (2)
Complex 2 was prepared by a similar procedure as described for
complex 1, using Ni(NO3)2ꢁ6H2O (0.40 g, 1.37 mmol) and {(2,5-
CH3)2C6H3O}2PS2Na (1.00 g, 2.77 mmol). The resulting solid was
recrystallized from a chloroform/n-hexane mixture (3:1) at room
temperature. Yield: 0.89 g (89%); M.p. 180–182 °C (dec); Anal. Calc.
for C32H36O4P2S4Ni: C, 52.40; H, 4.95; S, 17.49; Ni, 8.00; Found: C,
52.36; H, 4.91; S, 17.42; Ni, 7.78%; IR (KBr, cmꢀ1): 1099 s
R1
R2
1. R1 = CH3, R2 = H3, R3 = CH3, R4 = H5, R5 = H6
2. R1 = CH3, R2 = H3, R3 = H4, R4 = CH3, R5 = H6
3. R1 = H2, R2 = CH3, R3 = CH3, R4 = H5, R5 = H6
4. R1 = H2, R2 = CH3, R3 = H4, R4 = CH3, R5 = H6
5. R1 = H2, R2 = CH3, R3 = Cl, R4 = H5, R5 = H6
[
m
(P)ꢀOꢀC], 876 s [
m
PꢀOꢀ(C)], 653 s [
m
PꢀS]asym, 578 m [
m
PꢀS]sym
,
372 w [
m
NiꢀS]; 1H NMR (CDCl3, ppm): 2.25 (s, 12H, 2–CH3), 2.34 (s,
Scheme 1. Ring labelling for NMR spectroscopic assignments of complexes 1–5.
12H, 5–CH3), 6.98 (d, J = 7.6 Hz, 4H, H3), 7.12 (d, J = 7.6 Hz, 4H, H4),
7.25 (s, 4H, H6); 13C NMR (CDCl3, ppm): 16.6 (2–CH3), 21.0 (5–CH3),
121.6 (C6), 126.1 (C4), 127.0 (C2–CH3), 131.1 (C3), 136.9 (C5–CH3),
149.4 (C1–O); 31P NMR (CDCl3, ppm): 84.8 (s).
2.3. Crystallography data collection and refinement
2.2.3. Synthesis of [{3,4-(CH3)2C6H3O}2PS2]2Ni (3)
Complex 3 was prepared by a similar procedure as described for
complex 1, using Ni(NO3)2ꢁ6H2O (0.40 g, 1.37 mmol) and
Crystallization of complexes 1, 4 and 5 was executed by very
slow evaporation of their saturated solutions in a chloroform/n-
hexane mixture (3:1) at room temperature, yielding suitable single